 |
|
|
|
expected outcome |
|
| | |
|
 |
- identification of high risk pharmaceutical products (PPs
- bioprobes for monitoring high risk PPs
- methods for clean up and concentration of PPs
- diagnostic HTSAs and LC-MS-MS methods for monitoring PPs
- knowledge of the mechanisms of action of PPs
- possible identification of novel fecundity markers
- possible correlation between human fecundity problems and dietary habits
- information on the extent of environmental and food contamination
- proof (or disproof) of the concept
- risk management models
- knowledge pools and platforms
|
|
|
|
|
|
